Menu
🇧🇪
Clouds of Care NV is an ISO 13485:2016 and ISO 27001:2013-certified MedTech company in Gent, Belgium housing CE-marked and FDA-cleared electrophysiology applications for clinicians and tailor-made solutions for clinical trials and research. Through its comprehensive CNS platform and strategic network of partners, Clouds of Care is revolutionizing care for people with Central Nervous System (CNS) disorders.
Clouds of Care, founded in 2016, is at the forefront of collaborative innovation in the clinical trials and medtech sectors, particularly focusing on central nervous system (CNS) disorders. The company was established by a diverse team of experts, including two engineers and a neurologist, whose shared vision was to enhance the treatment landscape for epilepsy patients. Initially, they developed Epilog, an innovative technology to stratify epilepsy patients based on their suitability for surgical interventions, a crucial step in personalized treatment plans.
Recognizing the broader potential of their technology, Clouds of Care started offering their technological insights and platform in clinical trials for epilepsy drugs and medical devices. Today, a significant 90% of the company’s revenue is derived from this area, underscoring their pivotal role in the epilepsy trial industry.
As Clouds of Care expanded its work with leading pharmaceutical companies, they identified a substantial need for comprehensive data integration and analysis across the entire clinical trial process. This insight has driven Clouds of care’s mission to transform into a holistic, end-to-end solution provider for clinical trial management and data aggregation within the full CNS domain. They will achieve this through the identification and onboarding of third-party vendors, such as data insights, hardware, patient forms, …
News Articles:
At TCD Capital, we are proud to have led their Series A round in a syndicate with Flanders Future Tech Fund & White Fund. We are looking forward to further support Clouds of Care in their journey to revolutionize clinical trial management. Their innovative platform will not only streamline the clinical trial process but also enhance the development of treatments for CNS disorders, ultimately improving patient outcomes worldwide.
TCD Capital is a fund manager based in Brussels and Antwerp investing in Scale-Ups primarily in Smart Living, Tech, and Life Sciences.
We seek to customise the content to the segments we serve.
These are both fund investors and the entrepreneurs with whom we have created alliances.
We are happy to keep in touch.
